We are constantly bombarded with information about risk and risk factors for heart disease. The numbers are often confusing, sometimes they are big (50 or 100 times the risk), sometimes they are small, and sometimes they are in percent form (20% higher, 300% higher). What does this information mean … Read More
Monthly Archives: March 2019
Ask the Pharmacy – Are you getting the lowest cost for your PCSK9 inhibitor?
The manufacturers of both PCSK9 inhibitors, Praluent and Repatha, have lowered the list price for these cholesterol-lowering treatments by 60% to $5,850 per year. As we reported in February, the FH Foundation continues … Read More
Editor’s note: Today, Mike Smith shares how high cholesterol and heart disease took a toll on his family for generations. Until the day he had a proper diagnosis of familial hypercholesterolemia, and he knew he could manage it.
My story goes back longer than I can remember. I have a great … Read More
Statins are one of the longest and most well-studied drugs that definitively provide positive results. In fact, the most-effective statins reduce cholesterol by 55-50% at their maximum dose. In addition, statins are cost-effective — 6 of the 7 statins are generic. While statins save lives world-wide, … Read More